From the Department of Pathology, University of Health Sciences Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey (Dursun).
Department of Pathology, Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey (Memis).
Arch Pathol Lab Med. 2024 Feb 1;148(2):206-214. doi: 10.5858/arpa.2022-0379-OA.
CONTEXT.—: The nature and associations of gallbladder (GB) "adenomyoma" (AM) remain controversial. Some studies have attributed up to 26% of GB carcinoma to AMs.
OBJECTIVE.—: To examine the true frequency, clinicopathologic characteristics, and neoplastic changes in GB AM.
DESIGN.—: Cholecystectomy cohorts analyzed were 1953 consecutive cases, prospectively with specific attention to AM; 2347 consecutive archival cases; 203 totally embedded GBs; 207 GBs with carcinoma; and archival search of institutions for all cases diagnosed as AM.
RESULTS.—: Frequency of AM was 9.3% (19 of 203) in totally submitted cases but 3.3% (77 of 2347) in routinely sampled archival tissue. A total of 283 AMs were identified, with a female to male ratio = 1.9 (177:94) and mean size = 1.3 cm (range, 0.3-5.9). Most (96%, 203 of 210) were fundic, with formed nodular trabeculated submucosal thickening, and were difficult to appreciate from the mucosal surface. Four of 257 were multifocal (1.6%), and 3 of 257 (1.2%) were extensive ("adenomyomatosis"). Dilated glands (up to 14 mm), often radially converging to a point in the mucosa, were typical. Muscle was often minimal, confined to the upper segment. Nine of 225 (4%) revealed features of a duplication. No specific associations with inflammation, cholesterolosis, intestinal metaplasia, or thickening of the uninvolved GB wall were identified. Neoplastic change arising in AM was seen in 9.9% (28 of 283). Sixteen of 283 (5.6%) had mural intracholecystic neoplasm; 7 of 283 (2.5%) had flat-type high-grade dysplasia/carcinoma in situ. Thirteen of 283 cases had both AM and invasive carcinoma (4.6%), but in only 5 of 283 (1.8%), carcinoma arose from AM (invasion was confined to AM, and dysplasia was predominantly in AM).
CONCLUSIONS.—: AMs have all the features of a malformative developmental lesion, and may not show a significant muscle component (ie, the name "adeno-myoma" is partly a misnomer). While most are innocuous, some pathologies may arise in AMs, including intracholecystic neoplasms, flat-type high-grade dysplasia or carcinoma in situ, and invasive carcinoma (1.8%, 5 of 283). It is recommended that gross examination of GBs include serial slicing of the fundus for AM detection and total submission if one is found.
胆囊(GB)“腺肌瘤”(AM)的性质和关联仍存在争议。一些研究表明,高达 26%的胆囊癌归因于 AM。
检查 GB AM 的真实频率、临床病理特征和肿瘤变化。
分析的胆囊切除术队列为 1953 例连续病例,前瞻性地特别关注 AM;2347 例连续存档病例;203 例完全嵌入的 GB;207 例有癌的 GB;并在各机构的存档中搜索所有诊断为 AM 的病例。
在完全提交的病例中,AM 的频率为 9.3%(20 例中的 19 例),但在常规取样的存档组织中为 3.3%(2347 例中的 77 例)。共发现 283 例 AM,男女比例为 1.9(177 例:94 例),平均大小为 1.3 厘米(范围,0.3-5.9)。大多数(96%,203 例中的 203 例)为底体,形成结节状小梁状黏膜下增厚,从黏膜表面难以察觉。257 例中有 4 例(1.6%)为多灶性,257 例中有 3 例(1.2%)为广泛性(“腺肌瘤病”)。扩张的腺体(最大可达 14 毫米),通常向黏膜处的一个点放射状汇聚,是典型的。肌肉通常很少,局限于上段。225 例中的 9 例(4%)显示出双重特征。与炎症、胆固醇沉着症、肠上皮化生或非受累胆囊壁增厚均无特定关联。在 AM 中发现的肿瘤性变化见于 9.9%(28 例中的 28 例)。283 例中有 16 例(5.6%)有腔内胆囊壁肿瘤;283 例中有 7 例(2.5%)有扁平型高级别异型增生/原位癌。283 例中有 13 例(4.6%)同时存在 AM 和浸润性癌,但仅在 283 例中有 5 例(1.8%),癌来自 AM(浸润局限于 AM,异型增生主要在 AM 中)。
AM 具有所有发育性病变的特征,可能没有明显的肌肉成分(即,“腺肌瘤”这个名称部分是用词不当)。虽然大多数是无害的,但 AM 中可能会出现一些病理变化,包括腔内肿瘤、扁平型高级别异型增生或原位癌以及浸润性癌(1.8%,283 例中的 5 例)。建议对胆囊进行大体检查时,包括对底部进行连续切片以发现 AM,如果发现 AM,则进行完全提交。